AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue ...
The AstraZeneca PLC ADR AZN advanced 2.86% to $70.94 Wednesday, on what proved to be an all-around favorable trading session ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback